Elicera To Advance Next-Gen Cell Therapies Following IPO

Interview With CEO Jamal El-Mosleh

 
• By William Masters
  
ELICERA HAS TWO CAR-T AND TWO ONCOLYTIC VIRUS CANDIDATES • Source: Alamy

More from Innovation

More from In Vivo